Results 51 to 60 of about 19,917 (245)

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an ¹⁸F-FDG PET/CT Case Report

Pharmaceuticals
New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have become a public health concern because of their toxicological profiles and their harmful physical/psychological effects.
Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, Stefania Chiappini, Giovanni Martinotti, Maria Lucia Calcagni, Gabriele Sani   +6 more
doaj   +1 more source

Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms [PDF]

, 1996
It has been hypothesized that a disturbance of glutathione (GSH) metabolism might be a common factor in many psychiatric disorders. The aim of the present study was to test this hypothesis in transient acute psychotic patients with distorted perceptions.
Bode, W.T. (Willem), Fekkes, D. (Durk), Pepplinkhuizen, L. (Lolke), Zijlstra, F.J. (Freek)   +3 more
core   +2 more sources

Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?

Clinical Neuropsychopharmacology and Addiction
Substance-induced psychoses (SIP) may offer a useful vantage point for exploring mechanisms underlying psychotic disorders and for examining the phenomenological specificities of schizophrenia. Clinical observations suggest that a clinically relevant subset of patients does not fully recover after an episode of substance-induced psychosis, raising the ...
Filippo Maria Ferro, Alessio Mosca
openaire   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Clinical Pharmacology &Therapeutics, EarlyView.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović, Kent W. Nilsson, Robert Fredriksson, Helgi B. Schiöth, Thiago C. Moulin   +4 more
wiley   +1 more source

Assessing the efficacy and safety of rTMS, tDCS, and DBS in treating auditory hallucinations: a scoping review

Frontiers in Human Neuroscience
Auditory hallucinations (AH)—the perception of sound in the absence of any external auditory stimulus—are among the most clinically significant and personally distressing symptoms encountered in psychiatry and neurology.
Jiejun Wang
doaj   +1 more source

Hallucinogens: mechanisms and medical complications [PDF]

, 2013
Thesis (M.A.)--Boston UniversityHallucinogens are drugs that alter consciousness by distorting primarily auditory and visual perception but they can affect any sensory system. Hallucinogens also affect judgment, orientation, memory, or emotion.
Chan, Ryan Harry Alexander
core   +1 more source

Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia? [PDF]

, 2017
Growing interest in gut and digestive processes and their potential link to brain and peripheral based inflammation or biobehavioral phenotypes has led to an increasing number of basic and translational scientific reports focused on the role of gut ...
Cadenhead, Kristen S, Depp, Colin, Joseph, Jamie, Schmid-Schönbein, Geert, Shih, Pei-An B   +4 more
core   +1 more source

Latent Trajectories of Body Mass Index and Depressive Symptoms in Inpatients With Anorexia Nervosa: Predictors and Outcomes

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Inpatient treatment aimed at weight restoration and psychiatric stabilization is often required for individuals with anorexia nervosa (AN). This study aimed to identify distinct trajectories of change in body mass index (BMI) and depressive symptoms during inpatient treatment, examine clinical predictors and outcomes, and test ...
Matteo Martini, Mie Sedoc Jørgensen, Cristiano Dani, Anne Bryde Christensen, Magnus Sjögren, Nadia Micali   +5 more
wiley   +1 more source

Mismatch negativity generation in the human 5HT agonist and NMDA antagonist model of psychosis [PDF]

, 2008
RATIONALE: Many studies have reported deficits of mismatch negativity (MMN) in schizophrenic patients. Pharmacological challenges with hallucinogens in healthy humans are used as models for psychotic states.
Karsten Heekeren, Jörg Daumann, Anna Neukirch, Carsten Stock, Wolfram Kawohl, Christine Norra, Till D. Waberski, Euphrosyne Gouzoulis-Mayfrank, WM Abi-Saab, K Alho, T Baldeweg, SV Catts, JD Cohen, E Gouzoulis-Mayfrank, E Gouzoulis-Mayfrank, K Heekeren, DC Javitt, DC Javitt, G Juckel, S Kahkonen, I Kreitschmann-Andermahr, I Kreitschmann-Andermahr, S Leung, GA Light, GA Light, PT Michie, R Naatanen, R Naatanen, R Naatanen, B Oranje, E Pekkonen, A Pfefferbaum, TW Picton, T Rinne, W Ritter, T Rosburg, DF Salisbury, H Tiitinen, J Todd, D Umbricht, D Umbricht, D Umbricht, D Umbricht, DS Umbricht, FX Vollenweider, TD Waberski, G Winterer   +46 more
core   +2 more sources